3rd Quarter 2018
Key topics in this quarter’s edition include:
- canakinumab: To reduce the risk of recurrent cardiovascular events in stable post-myocardial infarction patients with elevated inflammatory markers, such as high-sensitivity C-reactive protein (hsCRP).
- brexanolone: Treatment of postpartum depression.
- baloxavir marboxil: Treatment of acute, uncomplicated influenza in patients 12 years of age and older.